itraconazole has been researched along with Lupus Nephritis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawana, S; Kikuchi, I; Kume, H; Mitsuishi, T; Morimoto, K; Ueno, T | 1 |
| Aomori, T; Araki, T; Fujita, Y; Hiromura, K; Nakamura, T; Nojima, Y; Okada, Y; Shimizu, R; Tomizawa, T; Yamamoto, K | 1 |
2 other study(ies) available for itraconazole and Lupus Nephritis
| Article | Year |
|---|---|
Systemic lupus erythematosus-associated cutaneous cryptococcosis treated successfully with an intermittent 3-day on/off cycle of itraconazole.
Topics: Adult; Antifungal Agents; Cryptococcosis; Dermatomycoses; Drug Administration Schedule; Female; Humans; Itraconazole; Lupus Erythematosus, Systemic; Lupus Nephritis | 2008 |
Analysis of cytochrome P450 gene polymorphism in a lupus nephritis patient in whom tacrolimus blood concentration was markedly elevated after administration of azole antifungal agents.
Topics: Antifungal Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Drug Interactions; Female; Genotype; Humans; Immunosuppressive Agents; Itraconazole; Lupus Nephritis; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2013 |